ΠΜΣ Βιοστατιστική - Ιατρική Σχολή και Τμήμα Μαθηματικών ΕΚΠΑ
Διάλεξη
"Modelling effects of time-varying exposures in time-to-event analyses with applications to assess drugs safety and effectiveness"
Michal Abrahamowicz
James McGill Professor of Biostatistics at McGill University, Montreal, Canada
Δευτέρα 15 Μαΐου 2017 15:00-16:00
Αίθουσα 2ου ορόφου
Εργαστηρίου Υγιεινής, Επιδημιολογίας και Ιατρικής Στατιστικής (Κτίριο 12) Ιατρική Σχολή, Μ. Ασίας 75, 11527 Γουδί
Σύντομο βιογραφικό του ομιλητή
Dr. Michal Abrahamowicz is a James McGill Professor of Biostatistics at McGill University, in Montreal, Canada. His statistical research aims at development and validation of new, flexible statistical methodology, with main focus on time-to-event (survival) analyses of prognostic and pharmaco-epidemiological studies. He has developed also new methods to control for different sources of bias in observational studies. His collaborative research includes arthritis, cardiovascular, and cancer epidemiology. He is the Nominated Principal Investigator on a major grant from the Drug Safety & Effectiveness Network (DSEN) of the Canadian Institutes for Health Research that develops new methods for longitudinal studies of drug safety and comparative effectiveness, and includes >35 faculty members from 14 universities across Canada. He published >300 peer-reviewed papers, and supervised 19 PhD and 14 MSc students, and 7 post-doctoral fellows. He is the co-chair of the international STRATOS initiative. In 2010- 14 he was a member of the Executive Committee of ISCB.
Διάλεξη
"Modelling effects of time-varying exposures in time-to-event analyses with applications to assess drugs safety and effectiveness"
Michal Abrahamowicz
James McGill Professor of Biostatistics at McGill University, Montreal, Canada
Δευτέρα 15 Μαΐου 2017 15:00-16:00
Αίθουσα 2ου ορόφου
Εργαστηρίου Υγιεινής, Επιδημιολογίας και Ιατρικής Στατιστικής (Κτίριο 12) Ιατρική Σχολή, Μ. Ασίας 75, 11527 Γουδί
Σύντομο βιογραφικό του ομιλητή
Dr. Michal Abrahamowicz is a James McGill Professor of Biostatistics at McGill University, in Montreal, Canada. His statistical research aims at development and validation of new, flexible statistical methodology, with main focus on time-to-event (survival) analyses of prognostic and pharmaco-epidemiological studies. He has developed also new methods to control for different sources of bias in observational studies. His collaborative research includes arthritis, cardiovascular, and cancer epidemiology. He is the Nominated Principal Investigator on a major grant from the Drug Safety & Effectiveness Network (DSEN) of the Canadian Institutes for Health Research that develops new methods for longitudinal studies of drug safety and comparative effectiveness, and includes >35 faculty members from 14 universities across Canada. He published >300 peer-reviewed papers, and supervised 19 PhD and 14 MSc students, and 7 post-doctoral fellows. He is the co-chair of the international STRATOS initiative. In 2010- 14 he was a member of the Executive Committee of ISCB.
- Διάλεξη ΠΜΣ Βιοστατιστικής (Ιατρική Σχολή και Τμήμα Μαθηματικών ΕΚΠΑ): Modelling effects of time-varying exposures in time-to-event analyses with applications to assess drugs safety and effectiveness by M. Abrahamowicz
- University of Crete Econ-Seminars 2/12/2020: Negative skewness of asset returns with positive time-varying risk premia by Δήμητρα Κυριακοπούλου
- Δευτέρα 26 Οκτωβρίου. 13:10 μμ. Αίθουσα Α32, Τμήμα Μαθηματικών του ΕΚΠΑ: Διακριτές q-κατανομές.
- Προκήρυξη ΕΣΠΑ για διδάσκοντα Στατιστικής στο Τμήμα Μαθηματικών ΕΚΠΑ - Εαρινό 2020-21
- AUEB SEMINARS - 29/5/2014: Meta-analysis of time-to-event end points
Permissions in this forum:
You cannot reply to topics in this forum